Physician of the Week is Dr. Seth Shaffer. His patient Megan was hesitant to seek further treatment after poor past experiences, but Dr. Shaffer's bedside manner, professionalism, & knowledge made her feel comfortable with testing & treatment again. DRMB.ca/MedWeek

Congratulations Dr. Kim! Well deserved!

@RZarychanski discusses the evidence surrounding plasmapharesis in septic shock. Fascinating rationale supporting his ongoing program on this question (PLEXSIS). #CCCF2022 @CCCTG_

Amazing to launch this pilot trial (Jan 2023) with Dr. Emily Rimmer in collaboration with hematology & critical care colleagues from across Canada. A new ‘spin’ on a lethal disease 🩸@EmilyRimmer20 @CCCTG_ @CCMB_Research @UM_RadyFHS @HSCFoundation @apheresisASFA @ASH_hematology

Honoured to be a CBC #future40 winner. Thanks @CBC for this incredible opportunity!

What a great learning opportunity, so glad to be part of the conference. Looking forward to sharing the results when the trial completes! @RZarychanski @mcisaac_d @CCMB_Research @HSCFoundation @ISME_MRCoM_UM #PratoAnaes2022

Privilege to be at the Prato Clinical Trials meeting listening to @BrettLHouston, MB's next gen clinical trialist, present our TRACTION trial on behalf of the MB/ON team @mcisaac_d @tscquizzato @gillies_mike @DrGrocott #PratoAnaes2022 @ISME_MRCoM_UM @CCMB_Research @HSCFoundation

🏥Entire ICUs filled with the same disease 👨‍👩‍👦Young folks fighting for their lives 👨‍⚕️🧑‍⚕️Colleagues on the news daily We’re strapping in for the highest ICU cases per capita over the next few weeks. Wish us luck, and do your part folks. #stayhome

Following on press releases - here is transparent public disclosure of INTERIM results from our multiplatform randomized trial of therapeutic anticoagulation vs. usual care in hospitalized patients with COVID-19. Manuscripts to follow asap. attacc.org/presentations

Important announcement from ATTACC, ⁦⁦@ACTIV4a⁩ and ⁦@remap_cap⁩: Full-dose blood thinners decreased need for life support and improved outcomes in hospitalized COVID-19 patients news.umanitoba.ca/blood-thin…

Note the data we were expecting to announce. This is why we do trials! The result of incredible collaboration - @remap_cap , @ACTIV4a and @ATTACC_COVID news.umanitoba.ca/internatio…